rentradВестник рентгенологии и радиологииJournal of radiology and nuclear medicine0042-46762619-0478Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists10.20862/0042-4676-2017-98-4-197-203rentrad-253Research ArticleКЛИНИЧЕСКИЕ СЛУЧАИCASE REPORTSПРИМЕНЕНИЕ ДИФФУЗИОННО-ТЕНЗОРНЫХ ИЗОБРАЖЕНИЙ ДЛЯ ОЦЕНКИ ОТВЕТА НА СТЕРЕОТАКСИЧЕСКОЕ РАДИОХИРУРГИЧЕСКОЕ ЛЕЧЕНИЕ МЕТАСТАТИЧЕСКОГО ПОРАЖЕНИЯ ГОЛОВНОГО МОЗГАASSESSMENT OF METASTATIC BRAIN TUMORS RESPONSE TO STEREOTACTIC RADIOSURGERY WITH DIFFUSION TENSOR IMAGINGhttps://orcid.org/0000-0002-8196-0518ТокаревА. С.TokarevA. S.

к. м. н., врач-нейрохирург, заведующий отделением «Центр радиохирургии»

Большая Сухаревская пл., 3, Москва, 129010, Российская Федерация

MD, PhD, Neurosurgeon, Head of Radiosurgery Department

Bol’shaya Sukharevskaya ploshchad’, 3, Moscow, 129010, Russian Federation

https://orcid.org/0000-0003-0007-8054СтепановВ. Н.StepanovV. N.

врач-рентгенолог

Большая Сухаревская пл., 3, Москва, 129010, Российская Федерация

Radiologist

Bol’shaya Sukharevskaya ploshchad’, 3, Moscow, 129010, Russian Federation

mail@rssklif.ruhttps://orcid.org/0000-0002-4534-8719РакВ. А.RakV. A.

врач-нейрохирург

Большая Сухаревская пл., 3, Москва, 129010, Российская Федерация

Neurosurgeon

Bol’shaya Sukharevskaya ploshchad’, 3, Moscow, 129010, Russian Federation

ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского Департамента здравоохранения города Москвы»РоссияSklifosovsky Research Institute for Emergency Medicine, Moscow Health DepartmentRussian Federation201706092017984197203Copyright © Токарев А.С., Степанов В.Н., Рак В.А., 20172017Токарев А.С., Степанов В.Н., Рак В.А.Tokarev A.S., Stepanov V.N., Rak V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.russianradiology.ru/jour/article/view/253

Одним из основных методов лечения множественного метастатического поражения головного мозга является лучевая терапия и такая ее современная разновидность, как стереотаксическое радиохирургическое лечение (СРХ). Применение СРХ у пациентов с метастатическим поражением головного мозга позволяет добиться локального контроля в 73–98% случаев (в зависимости от гистологического строения метастаза). Важнейшей задачей послеоперационного периода является оценка ответа опухоли на проведенное лечение и дифференцирование продолженного роста от лучевого некроза. В статье представлен клинический случай, демонстрирующий первый опыт использования диффузионно-тензорной магнитно-резонансной томографии для решения этой задачи.

Metastatic brain tumors – one of the most actual problems of neurooncology. Currently, whole brain radiotherapy and stereotactic radiosurgery are the main treatment methods of this pathology. The assessment of tumor’s response to irradiation is very important issue in postoperative period. We attempted solve it by using diffusion tensor imaging.

магнитно-резонансная томографиядиффузионно-тензорные изображениятрактографиядиффузиягамма-ножстереотаксическое радиохирургическое лечениеметастазыmagnetic resonanse imagingdiffusion tensor imagingtractographydiffusiongamma-knifestereotactic radiosurgerymetastasesReferencesLippitz B., Lindquist C., Paddick I., Peterson D., O’Neill K., Beaney R. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat. Rev. [Internet]. 2014; 40 (1): 48–59.Lippitz B., Lindquist C., Paddick I., Peterson D., O’Neill K., Beaney R. Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat. Rev. [Internet]. 2014; 40 (1): 48–59.Nayak L., Lee E.Q., Wen P.Y. Epidemiology of brain metastases. Curr. Oncol. Rep. 2012; 14 (1): 48–54.Nayak L., Lee E.Q., Wen P.Y. Epidemiology of brain metastases. Curr. Oncol. Rep. 2012; 14 (1): 48–54.Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363 (9422): 1665–72.Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C. et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 2004; 363 (9422): 1665–72.McTyre E., Scott J., Chinnaiyan P. Whole brain radiotherapy for brain metastasis. Surg. Neurol. Int. 2013; 4 (Suppl. 4): S236–44.McTyre E., Scott J., Chinnaiyan P. Whole brain radiotherapy for brain metastasis. Surg. Neurol. Int. 2013; 4 (Suppl. 4): S236–44.Fink K.R., Fink J.R. Imaging of brain metastases. Surg. Neurol. 2013; 4 (Suppl. 4): S209–19.Fink K.R., Fink J.R. Imaging of brain metastases. Surg. Neurol. 2013; 4 (Suppl. 4): S209–19.Juhász C., Dwivedi S., Kamson D.O., Michelhaugh S.K., Mittal S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol. Imaging. 2014; 13 (6).Juhász C., Dwivedi S., Kamson D.O., Michelhaugh S.K., Mittal S. Comparison of amino acid positron emission tomographic radiotracers for molecular imaging of primary and metastatic brain tumors. Mol. Imaging. 2014; 13 (6).Buck A.K., Herrmann K., Stargardt T., Dechow T., Krause B.J., Schreyögg J. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J. Nucl. Med. Technol. 2010; 38 (1): 6–17.Buck A.K., Herrmann K., Stargardt T., Dechow T., Krause B.J., Schreyögg J. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. J. Nucl. Med. Technol. 2010; 38 (1): 6–17.Jennings D., Hatton B.N., Guo J., Galons J.-P., Trouard T.P., Raghunand N. et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia. 2002; 4 (3): 255–62.Jennings D., Hatton B.N., Guo J., Galons J.-P., Trouard T.P., Raghunand N. et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia. 2002; 4 (3): 255–62.Chenevert T.L., Meyer C.R., Moffat B., Rehemtulla A., Mukherji S.K., Gebarski S.S. et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol. Imaging. 2002; 1 (4): 336–43.Chenevert T.L., Meyer C.R., Moffat B., Rehemtulla A., Mukherji S.K., Gebarski S.S. et al. Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol. Imaging. 2002; 1 (4): 336–43.Chenevert T.L., Stegman L.D., Taylor J.M., Robertson P.L., Greenberg H.S., Rehemtulla A. et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J. Natl. Cancer. Inst. 2000; 92 (24): 2029–36.Chenevert T.L., Stegman L.D., Taylor J.M., Robertson P.L., Greenberg H.S., Rehemtulla A. et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J. Natl. Cancer. Inst. 2000; 92 (24): 2029–36.Hall D.E., Moffat B.A., Stojanovska J., Johnson T.D., Li Z., Hamstra D.A. et al. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin. Cancer Res. 2004; 10 (23): 7852–9.Hall D.E., Moffat B.A., Stojanovska J., Johnson T.D., Li Z., Hamstra D.A. et al. Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin. Cancer Res. 2004; 10 (23): 7852–9.Ross B.D., Moffat B., Lawrence T.S., Mukherji S.K., Gebarski S.S., Quint D.J. et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol. Cancer. Ther. 2003; 2: 581–7.Ross B.D., Moffat B., Lawrence T.S., Mukherji S.K., Gebarski S.S., Quint D.J. et al. Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol. Cancer. Ther. 2003; 2: 581–7.Basser P.J., Mattiello J., Lebihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. Series B. 1994; 103: 247–54.Basser P.J., Mattiello J., Lebihan D. Estimation of the effective self-diffusion tensor from the NMR spin echo. J. Magn. Reson. Series B. 1994; 103: 247–54.Tournier J.D., Calamante F., Gadian D.G., Connelly A. Direct estimation of the fiber orientation density function from diffusion-weighted MRI data using spherical deconvolution. Neuroimage. 2004; 23 (3): 1176–85.Tournier J.D., Calamante F., Gadian D.G., Connelly A. Direct estimation of the fiber orientation density function from diffusion-weighted MRI data using spherical deconvolution. Neuroimage. 2004; 23 (3): 1176–85.Perrin M., Poupon C., Cointepas Y., Rieul B., Golestani N., Pallier C. et al. Fiber tracking in q-ball fields using regularized particle trajectories. Inf. Process. Med. Imaging. 2005; 3565: 52–63.Perrin M., Poupon C., Cointepas Y., Rieul B., Golestani N., Pallier C. et al. Fiber tracking in q-ball fields using regularized particle trajectories. Inf. Process. Med. Imaging. 2005; 3565: 52–63.Parker G.J.M., Alexander D.C. Probabilistic anatomical connectivity derived from the microscopic persistent angular structure of cerebral tissue. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2005; 360 (1457): 893–902.Parker G.J.M., Alexander D.C. Probabilistic anatomical connectivity derived from the microscopic persistent angular structure of cerebral tissue. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 2005; 360 (1457): 893–902.

The authors declare that there are no conflicts of interest present.